Cointime

  • Haberler
  • Haber
  • Para Birimi
  • Köşe Yazısı
  • Etkinlik
  • Bitcoin $90,288.63 -0.09%
  • Ethereum $3,111.51 +0.67%
  • BNB $897.22 +1.68%
  • Optimism $0.32 +2.28%
  • Arbitrum $0.22 +4.09%
  • Solana $133.08 +0.39%
  • Polygon $0.22 +2.77%
  • Cosmos $2.18 +1.71%
  • Avalanche $13.36 +1.44%
  • Bitcoin $90,288.63 -0.09%
  • Ethereum $3,111.51 +0.67%
  • BNB $897.22 +1.68%
  • Optimism $0.32 +2.28%
  • Arbitrum $0.22 +4.09%
  • Solana $133.08 +0.39%
  • Polygon $0.22 +2.77%
  • Cosmos $2.18 +1.71%
  • Avalanche $13.36 +1.44%
Home / Karyopharm Therapeutics / investors

Karyopharm Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
5
14
Karyopharm Therapeutics is funded by 14 investors. Avidity Partners and Foresite Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Avidity Partners Yes Post-IPO Equity
Foresite Capital Yes Series B
Chione Yes Series A
Multiple Myeloma Research Foundation Yes Grant
Adage Capital Management - Post-IPO Equity
Armistice Capital - Post-IPO Equity
HealthCor Partners - Post-IPO Equity
Heights Capital Management - Post-IPO Equity
Marshall Wace - Post-IPO Equity
Rubric Capital Management - Post-IPO Equity
SilverArc Capital - Post-IPO Equity
Surveyor Capital - Post-IPO Equity
Delphi Ventures - Series B
New Leaf Venture Partners - Series B

Contact

Newton,Massachusetts,United States
+1 617 658 0600
Cointime
İçerikler
  • Haberler
  • Girişimler
  • Araştırmalar
  • Teknoloji
  • Etkinlik
Şirket.
  • Hakkımızda
  • Reklam İşbirliği
  • Sorumluluk Reddi
  • © 2023 Cointime. Tüm Hakları Saklıdır
  • Gizlilik Politikası
  • Hizmet Şartları